Dilatative Kardiomyopathie und ICD-Therapie

Abstract

One third of the patients with idiopathic dilated cardiomyopathy (IDC) suffer from sudden cardiac death. Risk stratification includes clinical and electrophysiological parameters. Studies published so far concerning sudden cardiac death in IDC do not show a clear advantage of implantable – cardioverter/defibrillator (ICD) – therapy. Only studies concerning „heart failure” patients, including patients with IDC, show a statistically significant advantage of ICD therapy, especially if there is an indication for cardiac resynchronization therapy (CRT).

Literatur

• 1 Li D, Tapscoft T, Gonzalez O. et al . Desmin mutations responsible for idiopathic dilated cardiomyopathy.  Circulation. 1999;  100 461-464
• 2 Hjalmarson B. et al. on behalf of the MERIT-HF Study Group . MERIT-HF mortality and morbidity data.  Basic Res Cardiol. 2000;  95 (Suppl. 1) 98-103
• 3 Saxon L, Bristow M, Boehmer J. et al . Predictors of sudden cardiac death and appropriate shock in the Comparsion of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial.  Circulation. 2006;  114 2766-2772
• 4 Grimm W, Christ M, Bach J. et al . Non-invasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: Results of the Marburg Cardiomyopathy Study.  Circulation. 2003;  108 2883-2891
• 5 Buxton A E, Lee K L, Fisher J D. et al . A randomized study of the prevention of sudden death in patients with coronary artery disease (MUSTT).  N Engl J Med. 1999;  341 1882-1890
• 6 Moss A J, Zareba W, Hall W J. et al . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction (MADIT I – II).  N Engl J Med. 2002;  346 877-883
• 7 Bänsch D, Antz M, Boczor S. et al . for the CAT Investigators: Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy. The Cardiomyopathy Trial (CAT).  Circulation. 2002;  105 1453-1457
• 8 Strickberger S A, Hummel J, Bartlett T. et al . Amiodarone Versus Implantable Cardioverter Defibrillator Trial: Randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia. AMIOVIRT.  Am Coll Cardiol. 2003;  41 1707-1712
• 9 Kadish A, Dyer A, Daubert J P. et al . for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.  N Engl J Med. 2004;  350 2151-2158
• 10 Bardy G, Lee K, Mark D. et al . for the SCD-HeFT Investigators: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.  N Engl J Med. 2005;  352 225-237
• 11 Cleland J, Daubert J C, Erdmann E. et al . for the Cardiac Resynchronization-Heart Failure.  N Engl J Med. 2005;  352 1539-1549
• 12 Moss A J, Hall W J, Cannom D S. et al . MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events.  N Engl J Med. 2009;  361 1329-1338